Answers are grounded in this paper and cite their sources.
Uncovers how 4-octyl itaconate regulates inflammation, indicating a potential for therapeutic use in sepsis.
Itaconate is an immunomodulatory metabolite that links metabolism and inflammation. Li et al. uncover a mechanism by which itaconate and 4-octyl itaconate suppress cytokine signaling through the alkylation of tyrosine kinase 2 and Janus kinase 1. This study reveals a direct metabolic control of inflammation and highlights its therapeutic potential in sepsis.
No takes yet. Share an insight, caveat, or question.
Voß-Willenbockel et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: